Boule Diagnostics
8.54 SEK -2.29%1 investor is following this company
Boule Diagnostics is a diagnostics company. The company develops, manufactures, and sells medical technology systems and consumables for blood cell counts to the healthcare industry. The greatest focus is on small and medium-sized hospitals, clinics, and laboratories, as well as on other diagnostic companies in both human and veterinary hematology. Operations are located in the European market, with headquarters in Spånga.
Revenue
-
EBIT %
-
P/E
13.34
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
BOUL
Daily low / high price
8.52 / 9.48
SEK
Market cap
331.63M SEK
Turnover
80.76K SEK
Volume
9.1K
Financial calendar
Interim report
2024-10-25
Annual report
2025-02-11
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
AB Grenspecialisten | 12.6 % | 12.6 % |
Svolder | 11.0 % | 11.0 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Boule Diagnostics AB: Boule Diagnostics - Inbjudan till presentation av delårsrapport Q2 2024
Boule Diagnostics AB: Kommuniké från Boule Diagnostics årsstämma den 8 maj 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools